DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
Rheumatoid arthritis is associated with five different pulmonary manifestations present in a high percentage of seropositive cases: exudative pleural effusion characterized by a very low glucose concentration; pulmonary nodules varying from a few millimeters to greater than 5 cm in diameter; rheumatoid nodules in association with coal workers’ pneumoconiosis (Caplan’s syndrome); diffuse interstitial fibrosis; and pulmonary vasculitis. With the exception of the nodules and the low glucose in the pleural fluid, patients with systemic lupus erythematosus (SLE) may have many of the same manifestations. Pleuritis and pneumonitis have also been described in Sjogren’s syndrome, polymyositis, and dermato-myositis. The lung is commonly involved in scleroderma presenting as pulmonary fibrosis and/or pulmonary hypertension.
- Idiopathic Pulmonary Fibrosis
- DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
- Hypersensitivity Pneumonitis
- OBLITERATIVE OR OBSTRUCTIVE PULMONARY HYPERTENSION
- EMBOLIC DISEASE
- CLINICAL MANIFESTATIONS
- Other Clearly Extrinsic Causes of Diffuse Infiltrative Lung Disease
- EFFECTS OF PULMONARY HYPERTENSION ON PULMONARY FUNCTION
- Miscellaneous
- TREATMENT
- CLINICAL FEATURES OF PULMONARY HYPERTENSION
- Pulmonary Vasculitis
- Pulmonary Hemorrhagic Disorders
- HYPERKINETIC PULMONARY HYPERTENSION
- SPECIFIC ENTITIES - DISEASES WITH KFiOWIi ETIOLOGIES -
- DIFFUSE INFILTRATIVE DISEASES OF THE LUNG
- PHYSIOLOGICAL EFFECTS OF PULMONARY HYPERTENSION ON CARDIAC FUNCTION
- POSTCAPILLARY PULMONARY HYPERTENSION
- Sarcoidosis
- CAUSES OF PULMONARY HYPERTENSION
- Pulmonary Infiltrates with Eosinophilia PIE